MMedication Read More How Will Ozempic and Wegovy Sales Aid NVO’s Upcoming Q3 Results?October 23, 2025 Novo Nordisk NVO is a dominant player in the cardiometabolic space, mainly due to the encouraging uptake of its…
HHealthcare Read More These 3 Beaten-Down Healthcare Stocks Could Have Farther to FallOctober 21, 2025 Moderna could tumble once again, if there’s a lack of positive news in its upcoming earnings release. Novo…
HHealthcare Read More Ozempic at Costco? Discount Giant Expands Into $100 Billion Weight-Loss Drug MarketOctober 19, 2025 Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Costco…
HHealthcare Read More 3 Top Healthcare Stocks to Buy in OctoberOctober 18, 2025 Novo Nordisk could get its momentum back with its oral Wegovy pill. Danaher is a proven market-beater trading…
MMedication Read More Trump’s $150 Ozempic? Oz cautions it’s not a done deal, but patients and doctors say it could be a gamechangerOctober 18, 2025 Janet McCaskill was on vacation in Arizona with her husband and best friend when she heard that President…
HHealthcare Read More Trump’s $150 Ozempic? Oz cautions it’s not a done deal, but patients and doctors say it could be a gamechangerOctober 17, 2025 Janet McCaskill was on vacation in Arizona with her husband and best friend when she heard that President…
EEntrepreneurship Read More 50 European corporates backing startups on the path to growth, innovation, and global impactOctober 9, 2025 Across Europe, big companies are becoming strong backers of startup innovation, and corporate venturing is widely used as…
HHealthcare Read More Fat-loss drug Mounjaro now India’s No. 2 pharma brand | India NewsOctober 8, 2025 NEW DELHI: Soaring demand for weight-loss therapies has brought Eli Lilly’s Mounjaro within striking distance of Indian pharma…
HHealthcare Read More Novo, Lilly weight-loss drugs should be first option obesity treatments, European doctors sayOctober 4, 2025 By Nancy Lapid (Reuters) -Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs should be the first medicines doctors…
HHealthcare Read More Novo, Lilly weight-loss drugs should be first option obesity treatments, European doctors sayOctober 4, 2025 By Nancy Lapid (Reuters) -Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs should be the first medicines doctors…
HHealthcare Read More Novo plans online launch for obesity pill once approved, Bloomberg News reportsOctober 4, 2025 (Reuters) -Danish drugmaker Novo Nordisk said it plans to make its new obesity pill available through telehealth platforms…
MMedication Read More Ozempic maker urges Ottawa to shut down online drug sales to AmericansOctober 2, 2025 OTTAWA — Novo Nordisk, the Danish drug company that makes Ozempic and Wegovy, wants the Canadian government to…